Given that gas, bone, and fat interfere with the transmission of sound waves, endoscopic ultrasound (EUS) was developed in the 1980s to overcome these limitations in transabdominal ultrasound imaging. Moreover, EUS is thought to be one of the most reliable and efficient diagnostic modalities for pancreatobiliary disease because of its superiority to any other modalities with respect to spatial resolution. Therefore, EUS has become widely used as a diagnostic modality in clinical practice Although EUS was first utilized in the diagnosis of pancreatobiliary diseases only 30 years ago, it has become widely used as a diagnostic modality in clinical practice.
Clinical management of pancreatobiliary diseases can be challenging since symptoms and signs of various benign and malignant conditions of the pancreatobiliary system may overlap. Accurate diagnosis would help to guide subsequent clinical management. However, differentiation between benign and malignant lesion and evaluation of progression in benign diseases such as chronic pancreatitis may not always be straightforward. Therefore, imaging enhancement techniques with EUS such as contrast-enhanced EUS and EUS elastography have made great advancement and play an important role for diagnosis. EUS is also superior to other modalities in terms of cytopathological diagnosis with EUS-guided fine-needle aspiration (EUS-FNA). Nowadays, EUS-FNA is used not only for diagnosis but also for tissue acquisition for cancer gene panel test.
The scope of this research topic is to review data on the current status of EUS and new data from prospective developments in next-generation EUS to diagnose pancreatobiliary diseases. With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and advances in a hot research area.
Given that gas, bone, and fat interfere with the transmission of sound waves, endoscopic ultrasound (EUS) was developed in the 1980s to overcome these limitations in transabdominal ultrasound imaging. Moreover, EUS is thought to be one of the most reliable and efficient diagnostic modalities for pancreatobiliary disease because of its superiority to any other modalities with respect to spatial resolution. Therefore, EUS has become widely used as a diagnostic modality in clinical practice Although EUS was first utilized in the diagnosis of pancreatobiliary diseases only 30 years ago, it has become widely used as a diagnostic modality in clinical practice.
Clinical management of pancreatobiliary diseases can be challenging since symptoms and signs of various benign and malignant conditions of the pancreatobiliary system may overlap. Accurate diagnosis would help to guide subsequent clinical management. However, differentiation between benign and malignant lesion and evaluation of progression in benign diseases such as chronic pancreatitis may not always be straightforward. Therefore, imaging enhancement techniques with EUS such as contrast-enhanced EUS and EUS elastography have made great advancement and play an important role for diagnosis. EUS is also superior to other modalities in terms of cytopathological diagnosis with EUS-guided fine-needle aspiration (EUS-FNA). Nowadays, EUS-FNA is used not only for diagnosis but also for tissue acquisition for cancer gene panel test.
The scope of this research topic is to review data on the current status of EUS and new data from prospective developments in next-generation EUS to diagnose pancreatobiliary diseases. With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and advances in a hot research area.
